AMGN
36
-3
AN
63
2
CMA
70
2
EMN
52
-3
APH
58
2
AMP
69
3
BAX
42
-5
D
43
-2
CRM
57
7
ABBV
57
-2
DTE
42
2
ES
45
5
CPB
37
-2
CL
56
-2
COST
48
-8
BBY
41
-9
AAL
50
-4
CF
48
3
CHRW
76
-3
CAT
76
2
AMGN
36
-3
AN
63
2
CMA
70
2
EMN
52
-3
APH
58
2
AMP
69
3
BAX
42
-5
D
43
-2
CRM
57
7
ABBV
57
-2
DTE
42
2
ES
45
5
CPB
37
-2
CL
56
-2
COST
48
-8
BBY
41
-9
AAL
50
-4
CF
48
3
CHRW
76
-3
CAT
76
2
Financhill
Back

Guardant Health, Inc. 10K Form

Buy
53

GH
Guardant Health, Inc.

Last Price:
$108.51
Seasonality Move:
-2.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GH News And Ratings

See the #1 stock for the next 7 days that we like better than GH

GH Financial Statistics

Sales & Book Value

Annual Sales: $739M
Cash Flow: $-45.8M
Price / Cash Flow: 0
Annual Sales: $-2.84
Price / Book: 32.59

Profitability

EPS (TTM): -3.21310
Net Income (TTM): $-398.8M
Gross Margin: $449.2M
Return on Equity: -8518.58%
Return on Assets: -28.58%

Guardant Health, Inc. Earnings Forecast

Key Guardant Health, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for GH is 60.79%.
  • The Selling, General & Administrative Expenses for GH have been equal to 73.75% of Gross Profit Margin.
  • The Research & Development expenses have been 47.06% of Revenue.
  • The Net Earning history of GH is -59.05% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Guardant Health, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: GH
CUSIP: 40131M
Website: guardanthealth.com

Debt

Debt-to-Equity Ratio: -3.74
Current Ratio: 3.5
Quick Ratio: 2.94

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GH Technical Analysis vs Fundamental Analysis

Buy
53
Guardant Health, Inc. (GH) is a Buy

Is Guardant Health, Inc. a Buy or a Sell?